Literature DB >> 18248614

GAT-1 regulates both tonic and phasic GABA(A) receptor-mediated inhibition in the cerebral cortex.

Luca Bragina1, Ivan Marchionni, Azar Omrani, Andrea Cozzi, Domenico E Pellegrini-Giampietro, Enrico Cherubini, Fiorenzo Conti.   

Abstract

gamma-Aminobutyric acid 1 (GAT-1) is the most copiously expressed GABA transporter; we studied its role in phasic and tonic inhibition in the neocortex using GAT-1 knockout (KO) mice. Immunoblotting and immunocytochemical studies showed that GAT-2 and GAT-3 levels in KOs were unchanged and that GAT-3 was not redistributed in KOs. Moreover, the expression of GAD65/67 was increased, whereas that of GABA or VGAT was unchanged. Microdialysis studies showed that in KOs spontaneous extracellular release of GABA and glutamate was comparable in WT and KO mice, whereas KCl-evoked output of GABA, but not of glutamate, was significantly increased in KOs. Recordings from layer II/III pyramids revealed a significant increase in GABA(A)R-mediated tonic conductance in KO mice. The frequency, amplitude and kinetics of spontaneous inhibitory post-synaptic currents (IPSCs) were unchanged, whereas the decay time of evoked IPSCs was significantly prolonged in KO mice. In KO mice, high frequency stimulation of GABAergic terminals induced large GABA(A)R-mediated inward currents associated with a reduction in amplitude and decay time of IPSCs evoked immediately after the train. The recovery process was slower in KO than in WT mice. These studies show that in the cerebral cortex of GAT-1 KO mice GAT-3 is not redistributed and GADs are adaptively changed and indicate that GAT-1 has a prominent role in both tonic and phasic GABA(A)R-mediated inhibition, in particular during sustained neuronal activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248614     DOI: 10.1111/j.1471-4159.2008.05273.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

Review 1.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  The Cerebellar GABAAR System as a Potential Target for Treating Alcohol Use Disorder.

Authors:  David J Rossi; Ben D Richardson
Journal:  Handb Exp Pharmacol       Date:  2018

3.  GABA transporter GAT1 prevents spillover at proximal and distal GABA synapses onto primate prefrontal cortex neurons.

Authors:  Guillermo Gonzalez-Burgos; Diana C Rotaru; Aleksey V Zaitsev; Nadezhda V Povysheva; David A Lewis
Journal:  J Neurophysiol       Date:  2008-12-10       Impact factor: 2.714

4.  Differential localization and function of GABA transporters, GAT-1 and GAT-3, in the rat globus pallidus.

Authors:  Xiao-Tao Jin; Jean-Francois Paré; Yoland Smith
Journal:  Eur J Neurosci       Date:  2011-03-17       Impact factor: 3.386

5.  Developmental exposure to the organochlorine insecticide endosulfan alters expression of proteins associated with neurotransmission in the frontal cortex.

Authors:  W Wyatt Wilson; Wellington Onyenwe; Joshua M Bradner; Sadie E Nennig; W Michael Caudle
Journal:  Synapse       Date:  2014-07-25       Impact factor: 2.562

6.  Functional expression of γ-amino butyric acid transporter 2 in human and guinea pig airway epithelium and smooth muscle.

Authors:  Sarah Zaidi; George Gallos; Peter D Yim; Dingbang Xu; Joshua R Sonett; Reynold A Panettieri; William Gerthoffer; Charles W Emala
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-05       Impact factor: 6.914

7.  Cytosolic Accumulation of L-Proline Disrupts GABA-Ergic Transmission through GAD Blockade.

Authors:  Gregg W Crabtree; Alan J Park; Joshua A Gordon; Joseph A Gogos
Journal:  Cell Rep       Date:  2016-10-04       Impact factor: 9.423

8.  Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia.

Authors:  Allison A Curley; Stephen M Eggan; Matt S Lazarus; Z Josh Huang; David W Volk; David A Lewis
Journal:  Neurobiol Dis       Date:  2012-10-26       Impact factor: 5.996

Review 9.  Fast synaptic inhibition in spinal sensory processing and pain control.

Authors:  Hanns Ulrich Zeilhofer; Hendrik Wildner; Gonzalo E Yévenes
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

10.  Enhanced tonic GABAA inhibition in typical absence epilepsy.

Authors:  David W Cope; Giuseppe Di Giovanni; Sarah J Fyson; Gergely Orbán; Adam C Errington; Magor L Lorincz; Timothy M Gould; David A Carter; Vincenzo Crunelli
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.